Association of TLR4 and TLR9 Gene Polymorphisms with the Risk and Progression of Cervical Lesions in HPV-Infected Women
Biomarkers in Medicine · 2023
DOI: 10.2217/bmm-2022-0702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarkers in Medicine, 2023. Verfasst von Chunlin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, 434000, China. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Papillomavirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Key research and development plan project supporting local special funds in the field of comprehensive health of Hubei Province, Project of Central Funds Guiding the Local Science and Technology Development of Hubei Province.
Abstract (Originalsprache)
Aim
Toll-like receptors involved in tumor-associated inflammatory response, this study aimed to investigate the role of TLR4 and TLR9 gene polymorphisms in the risk and progression of HPV-related cervical lesions. Materials & methods: A total of 220 cervical lesion patients and 227 healthy controls were enrolled. Single-nucleotide polymorphisms were genotyped using PCR-restriction fragment length polymorphism.
Results
A significantly decreased risk of cervical lesions was observed to be associated with the TLR4 rs10116253 (C), rs1927911 (T) and rs10759931 (G) mutant alleles. rs187084-rs1927911-HPV-16/18 was the best interaction model to affect cervical lesion risk.
Conclusion
TLR4 rs10116253, rs1927911 and rs10759931 were potential biomarkers for cervical lesion susceptibility. Cervical lesions are common diseases in women worldwide. Infection with high-risk HPV over a long time is a major risk factor for cervical lesions. Toll-like receptors play an important role in the natural defenses against virus infection. However, they may promote inflammation related to cancer development. The aim of this research was to investigate the association between TLR4/TLR9 gene polymorphisms and the risk/progression of HPV-related cervical lesions. The study found that mutant allele carriers of TLR4 rs10116253 (CT and CT + CC), rs1927911 (CT and CT + TT) and rs10759931 (AG and AG + GG) had a significantly decreased risk of cervical lesions compared with those carrying the wild-type homozygous genotypes. The interaction between TLR4/TLR9 gene polymorphisms and HPV-16/18 infection influenced cervical lesion risk. These results can be used to evaluate the risk of cervical lesions in women with high-risk HPV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, 434000, China.
- Department of Pathology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, 434000, China.
- Department of Immunology, Health Science Center, Yangtze University, Jingzhou, Hubei, 434000, China.
ORCID-Profile: Chunlin Zhang, Zhiping Yang, Ping Luo, Mengxia Ye, Ping Gong, Quan Gong, Bing Mei
Förderung
- Key research and development plan project supporting local special funds in the field of comprehensive health of Hubei Province
- Project of Central Funds Guiding the Local Science and Technology Development of Hubei Province
Zitieren
APA
Zhang, C., Yang, Z., Luo, P., Ye, M., Gong, P., Gong, Q., & Mei, B. (2023). Association of TLR4 and TLR9 Gene Polymorphisms with the Risk and Progression of Cervical Lesions in HPV-Infected Women. Biomarkers in Medicine. https://doi.org/10.2217/bmm-2022-0702
Vancouver
Zhang C, Yang Z, Luo P, Ye M, Gong P, Gong Q, et al. Association of TLR4 and TLR9 Gene Polymorphisms with the Risk and Progression of Cervical Lesions in HPV-Infected Women. Biomarkers in Medicine. 2023. doi:10.2217/bmm-2022-0702
BibTeX
@article{Zhang2023,
author = {Zhang, Chunlin and Yang, Zhiping and Luo, Ping and Ye, Mengxia and Gong, Ping and Gong, Quan and Mei, Bing},
title = {Association of TLR4 and TLR9 Gene Polymorphisms with the Risk and Progression of Cervical Lesions in HPV-Infected Women},
journal = {Biomarkers in Medicine},
year = {2023},
doi = {10.2217/bmm-2022-0702}
}
EUVIMED